Serum concentrations of PRL, LH and FSH were examined in 17 perimenopausal women with dysfunctional uterine bleeding (PDUB group), after stimulation with exogenous GnRH (a 100-µg i.v. bolus dose), and endogenous GnRH (as induced by an estrogen challenge test). Five normal cycling women during the follicular phase of the cycle were used as control (FP group). Exogenous GnRH induced increments in the concentration of PRL, FSH and LH in PDUB and FP women. Increases were statistically higher for FSH (p < 0.001) and LH (p < 0.01), but not for PRL, in the FP group. No significant correlation was found between LH-PRL or FSH-PRL in PDUB women. A positive correlation was found when the maximal LH percent change for each case was compared with the simultaneous PRL percent value (r = 0.83, p < 0.001) during the estrogen test. We conclude that, as shown by previous studies in both hypogonadal and normal women, also in this perimenopausal model exogenous GnRH induces secretion of PRL, LH and FSH, and that a positive correlation exists between LH and PRL under the finely modulated stimulation of gonadotrophs by endogenous GnRH.

Keywords:
Gonadotropin-releasing hormone, Gonadotropins, Prolactin, Perimenopause
This content is only available via PDF.
© 1988 S. Karger AG, Basel
1988
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.